Showing results (101-110 of 113) with videos related to

Sort By:
Pageof 12
Molecular Medicine Reports|August 30, 2017
[Corrigendum] Death receptor 5 expression is inversely correlated with prostate cancer progressionAngeles Hernandez-Cueto, Daniel Hernandez-Cueto, Gabriela Antonio-Andres, et al.
Leukemia & Lymphoma|April 5, 2018
Role of Yin Yang-1 (YY1) in the transcription regulation of the multi-drug resistance (MDR1) geneGabriela Antonio-Andrés, Jesus Rangel-Santiago, Belen Tirado-Rodríguez, et al.
Future Microbiology|June 1, 2018
Dual role of hypoxia-inducible factor 1 α in experimental pulmonary tuberculosis: its implication as a new therapeutic targetGuillermina J Baay-Guzman, Marco A Duran-Padilla, Jesus Rangel-Santiago, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 1, 2026
Circulating Tumor Cells as the Liquid Biopsy Foray into Noninvasive Colorectal Cancer ScreeningMario I Vega, Sandrine Billet, Alessio Pigazzi, et al.
Tuberculosis (Edinburgh, Scotland)|January 21, 2016
A novel role of Yin-Yang-1 in pulmonary tuberculosis through the regulation of the chemokine CCL4Jesus F Rangel-Santiago, Guillermina J Baay-Guzman, Marco A Duran-Padilla, et al.
Respiratory Research|July 25, 2012
HIF-1 expression is associated with CCL2 chemokine expression in airway inflammatory cells: implications in allergic airway inflammationGuillermina J Baay-Guzman, Ilona G Bebenek, Michelle Zeidler, et al.
Allergy|April 27, 2011
Hypoxia inducible factor promotes murine allergic airway inflammation and is increased in asthma and rhinitisS Huerta-Yepez, G J Baay-Guzman, I G Bebenek, et al.
Scientific Reports|February 22, 2019
Biochar reduces the efficiency of nitrification inhibitor 3,4-dimethylpyrazole phosphate (DMPP) mitigating N2O emissionsT Fuertes-Mendizábal, X Huérfano, I Vega-Mas, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 28, 2025
Effectiveness of the Adjuvanted Recombinant Zoster Vaccine in Adults ≥50 Years in the United StatesHung-Fu Tseng, Lina S Sy, Bradley K Ackerson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 12, 2025
Adjuvanted recombinant zoster vaccine is effective against herpes zoster ophthalmicus, and is associated with lower risk of acute myocardial infarction and stroke in adults aged ≥50 yearsEmily Rayens, Lina S Sy, Lei Qian, et al.
Pageof 12